Form Type and Filing Date: This is a Form 8-K Current Report filed by Dexcom Inc. on February 12, 2026, reporting events as of the same date. Item 2.02 - Results of Operations and Financial Condition: The filing indicates disclosure of results of operations and financial condition information, though the specific financial details are not fully visible in the provided document excerpt. Item 9.01…

Our analysis rates this filing BULLISH. This earnings announcement presents an exceptionally positive financial picture with no material concerns identified. DexCom demonstrated strong double-digit revenue growth (16% FY, 13% Q4) significantly outpacing guidance expectations, coupled with…

Concern level: LOW (1.2/10).

Notable risk changes: Strong Q4 2025 financial performance: Revenue grew 13% YoY to $1.260B with GAAP operating margin expanding 860 basis points to 25.6%; Full year 2025 revenue reached $4.662B (16% growth) with operating income of $911.8M (19.6% margin), demonstrating operational leverage and profitability improvement; 2026 guidance reiterates 11-13% revenue growth ($5.16-$5.25B) with stable-to-improving margins…

The model predicts DXCM will underperform the S&P 500 by about 0.1% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.